Common Variants in the Adiponectin Gene (ADIPOQ) Associated With Plasma Adiponectin Levels, Type 2 Diabetes, and Diabetes-Related Quantitative Traits The Framingham Offspring Study

被引:128
|
作者
Hivert, Marie-France [1 ,2 ]
Manning, Alisa K. [3 ]
McAteer, Jarred B. [4 ,5 ]
Florez, Jose C. [2 ,4 ,5 ]
Dupuis, Josee [3 ]
Fox, Caroline S. [6 ,7 ]
O'Donnell, Christopher J. [2 ,7 ]
Cupples, L. Adrienne [3 ]
Meigs, James B. [1 ,2 ]
机构
[1] Massachusetts Gen Hosp, Div Gen Med, Boston, MA 02114 USA
[2] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA
[3] Boston Univ, Dept Biostat, Sch Publ Hlth, Boston, MA 02215 USA
[4] Massachusetts Gen Hosp, Dept Med, Ctr Human Genet Res & Diabet Unit, Boston, MA 02114 USA
[5] Broad Inst Harvard & MIT, Program Med & Populat Genet, Cambridge, MA USA
[6] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Endocrinol Diabet & Hypertens, Boston, MA 02115 USA
[7] NHLBI, Framingham Heart Study, Framingham, MA USA
基金
美国国家卫生研究院;
关键词
D O I
10.2337/db08-0700
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE-Variants in ADIPOQ have been inconsistently associated with adiponectin levels or diabetes. Using comprehensive linkage disequilibrium mapping, we genotyped single nucleotide polymorphisms (SNPs) in ADIPOQ to evaluate the association of common variants with adiponectin levels and risk of diabetes. RESEARCH DESIGN AND METHODS-Participants in the Framingham Offspring Study (n = 2,543, 53% women) were measured for glycemic phenotypes and incident diabetes over 28 years of follow-up; adiponectin levels were quantified at exam 7. We genotyped 22 tag SNPs that captured common (minor allele frequency >0.05) variation at r(2) > 0.8 across ADIPOQ plus 20 kb 5' and 10 kb 3' of the gene. We used linear mixed effects models to test additive associations of each SNP with adiponectin levels and glycemic phenotypes. Hazard ratios (HRs) for incident diabetes were estimated using an adjusted Cox proportional hazards model. RESULTS-Two promoter SNPs in strong linkage disequilibrium with each other (r(2) = 0.80) were associated with adiponectin levels (rs17300539; P-nominal [P-n] 2.6 x 10(-8); P-empiric [P-e] = 0.0005 and rs822387; P-n = 3.8 x 10(-5); P-e = 0.001). A 3'-untranslated region (3'UTR) SNP (rs6773957) was associated with adiponectin levels (P-n = 4.4 x 10(-4); P-e = 0.005). A nonsynonymous coding SNP (rs17366743, Y111H) was confirmed to be associated with diabetes incidence (HR 1.94 [95% CI 1.16-3.25] for the minor C allele; P-n = 0.01) and with higher mean fasting glucose over 28 years of follow-up (P-n = 0.0004; P-e = 0.004). No other significant associations were found with other adiposity and metabolic phenotypes. CONCLUSIONS-Adiponectin levels are associated with SNPs in two different regulatory regions (5' promoter and 3'UTR), whereas diabetes incidence and time-averaged fasting glucose are associated with a missense SNP of ADIPOQ. Diabetes 57: 3353-3359, 2008
引用
收藏
页码:3353 / 3359
页数:7
相关论文
共 50 条
  • [41] Effects of ADRA2A genetic variants on type 2 diabetes-related traits
    Hamad, N.
    Bego, T.
    Causevic, A.
    Halilovic, L.
    Asimi, Z. Velija
    Semiz, S.
    FEBS JOURNAL, 2016, 283 : 366 - 366
  • [42] Plasma omentin levels are inversely associated with atherosclerosis in type 2 diabetes patients with increased plasma adiponectin levels: a cross-sectional study
    Nishimura, Masami
    Morioka, Tomoaki
    Hayashi, Mariko
    Kakutani, Yoshinori
    Yamazaki, Yuko
    Kurajoh, Masafumi
    Mori, Katsuhito
    Fukumoto, Shinya
    Shioi, Atsushi
    Shoji, Tetsuo
    Inaba, Masaaki
    Emoto, Masanori
    CARDIOVASCULAR DIABETOLOGY, 2019, 18 (01)
  • [43] Plasma omentin levels are inversely associated with atherosclerosis in type 2 diabetes patients with increased plasma adiponectin levels: a cross-sectional study
    Masami Nishimura
    Tomoaki Morioka
    Mariko Hayashi
    Yoshinori Kakutani
    Yuko Yamazaki
    Masafumi Kurajoh
    Katsuhito Mori
    Shinya Fukumoto
    Atsushi Shioi
    Tetsuo Shoji
    Masaaki Inaba
    Masanori Emoto
    Cardiovascular Diabetology, 18
  • [44] Common adiponectin gene variants show different effects on risk of cardiovascular disease and type 2 diabetes in European subjects
    Gable, D. R.
    Matin, J.
    Whittall, R.
    Cakmak, H.
    Li, Ka Wah
    Cooper, J.
    Miller, G. J.
    Humphries, S. E.
    ANNALS OF HUMAN GENETICS, 2007, 71 : 453 - 466
  • [45] Adiponectin gene 45T>G polymorphism is not associated to plasma adiponectin in a cohort of patients with type 2 diabetes from Romania
    Kacso, Ina M.
    Trifa, Adrian P.
    Popp, Radu A.
    Bondor, Cosmina I.
    Farcas, Marius F.
    Lenghel, Alina R.
    Moldovan, Diana
    Rusu, Crina
    Nita, Cristina
    Pop, Ioan V.
    Gherman, Caprioara M.
    Hancu, Nicolae D.
    REVISTA ROMANA DE MEDICINA DE LABORATOR, 2012, 20 (01): : 73 - 79
  • [46] Effect of aerobic exercise on plasma adiponectin levels and insulin resistance in type 2 diabetes
    Yokoyama, H
    Emoto, M
    Araki, T
    Fujiwara, S
    Motoyama, K
    Morioka, T
    Koyama, H
    Shoji, T
    Okuno, Y
    Nishizawa, Y
    DIABETES CARE, 2004, 27 (07) : 1756 - 1758
  • [47] Plasma adiponectin levels, cardiovascular risk factors, and coronary atherosclerosis in type 2 diabetes
    Mehta, NN
    Schutta, M
    Wolfe, ML
    Iqbal, N
    Kimmel, SE
    Rader, DJ
    Reilly, MP
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2004, 24 (05) : E42 - E43
  • [48] Decreased levels of plasma adiponectin in prediabletes, type 2 diabetes and coronary artery disease
    Yaturu, S
    Bridges, J
    Reddy, DRRS
    MEDICAL SCIENCE MONITOR, 2006, 12 (01): : CR17 - CR20
  • [49] Role of adiponectin in Japanese patients with type 2 diabetes complicated by hypertriglyceridemia: Changes in adiponectin levels associated with improvement in hypertriglyceridemia
    Akutsu, T
    Mori, Y
    Tajima, N
    DIABETES, 2004, 53 : A116 - A117
  • [50] Effect of ADIPOQ gene variability on adiponectin circulating levels, insulin resistance features, and type 2 diabetes:: A meta-analysis of 32 studies
    Menzaghi, Claudia
    Trischitta, Vincenzo
    Doria, Alessandro
    DIABETES, 2007, 56 : A294 - A294